Wednesday, July 8, 2026

pharma · Heart Failure · Atrial Fibrillation · RYTM

Rhythm Pharmaceuticals Netherlands

Rhythm Pharmaceuticals Netherlands clinical programs — 73 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

BRIGHTLANDS CHEMELOT CAMPUS, VAN ITERSON BUILDING, BURGEMEESTER LEMMENSSTRAAT 352, Geleen, nl HQ
2014 Founded
10 Employees
Public company Type
RYTM · NYSE Ticker
Company details
Status
Public
HQ
BRIGHTLANDS CHEMELOT CAMPUS, VAN ITERSON BUILDING, BURGEMEESTER LEMMENSSTRAAT 352, Geleen, nl
Founded
2014
Employees
10
Programs
73
Drugs
38
Patents
12
Intelligence · Clinical Programs

Rhythm Pharmaceuticals Netherlands projects

73 ClinicalTrials.gov programs sponsored by Rhythm Pharmaceuticals Netherlands.

Rhythm Pharmaceuticals Netherlands has 73 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 2 of 2
  1. DOAC

    Rhythm Pharmaceuticals Netherlands B.V.

    Ventricular Tachycardia

    approved small molecule completed

    1 trial
  2. Dual chamber pacemeker

    Rhythm Pharmaceuticals Netherlands B.V.

    Syncope

    approved other completed

    1 trial
  3. Fill out Questionnaire

    Rhythm Pharmaceuticals Netherlands B.V.

    Bradycardia

    approved other completed

    1 trial
  4. Freezor® Cardiac Cryoablation Catheter CryoConsole System

    Rhythm Pharmaceuticals Netherlands B.V.

    Tachycardia, Atrioventricular Nodal Reentry

    approved other completed

    1 trial
  5. ICD Ablation plus VT-ablation

    Rhythm Pharmaceuticals Netherlands B.V.

    Tachycardia, Ventricular

    approved other completed

    1 trial
  6. Implantable Cardiac Defibrillator

    Rhythm Pharmaceuticals Netherlands B.V.

    Tachycardia, Ventricular

    approved other completed

    2 trials
  7. Implantable Cardiac Monitor

    Rhythm Pharmaceuticals Netherlands B.V.

    Chagas Disease

    approved other terminated

    1 trial
  8. Implantable Defibrillator

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Disease

    approved other completed

    1 trial
  9. Implantable cardioverter defibrillator

    Rhythm Pharmaceuticals Netherlands B.V.

    Acute Myocardial Infarction

    approved other completed

    1 trial
  10. KCHRF-DASH-AF-0002

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmias, Cardiac

    approved small molecule active

    1 trial
  11. LV dp/dt pressure measurement

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial
  12. Managed Ventricular Pacing programmed ON/OFF

    Rhythm Pharmaceuticals Netherlands B.V.

    Cardiovascular Diseases

    approved other completed

    1 trial
  13. Medtronic AT500

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial
  14. Medtronic Endeavor Resolute

    Rhythm Pharmaceuticals Netherlands B.V.

    Coronary Artery Disease

    approved other completed

    1 trial
  15. Monthly Review Arm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial
  16. Pacemaker Medtronic EnRhythm

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial
  17. RF Ablation procedure

    Rhythm Pharmaceuticals Netherlands B.V.

    Paroxysmal Atrial Fibrillation

    approved other completed

    1 trial
  18. Reveal® XT Insertable Cardiac Monitor

    Rhythm Pharmaceuticals Netherlands B.V.

    Cryptogenic Symptomatic Transient Ischemic Attack

    approved other completed

    1 trial
  19. Search AV+ algorithm

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmia, Sinus

    approved other terminated

    1 trial
  20. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Healthy

    approved small molecule completed

    1 trial
  21. Stent

    Rhythm Pharmaceuticals Netherlands B.V.

    Ischemic Heart Disease

    approved other completed

    1 trial
  22. TYRX™ Absorbable Antibacterial Envelope

    Rhythm Pharmaceuticals Netherlands B.V.

    CIED Related Infection

    approved other completed

    1 trial
  23. Use of an Implantable Loop Recorder

    Rhythm Pharmaceuticals Netherlands B.V.

    Syncope

    approved other completed

    1 trial
  24. early standardised rhythm control

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial
  25. Chronotropic Incompetence Diagnostic Algorithm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    other terminated

    1 trial

Frequently asked questions

How many clinical projects does Rhythm Pharmaceuticals Netherlands have?

73 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.